Oncology Alliance; Apeiron, CCRI And SIOPEN Join Forces Against Neuroblastoma
6/23/2011
Today, Vienna based Apeiron announced the conclusion of an agreement with the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN). Thereby, Apeiron obtains the rights to further develop, file for regulatory approval and market the antibody ch14.18...
A treatment that has virtually no side effects has been found to be an effective weapon for fighting early-stage breast cancer, according to results of a clinical trial conducted at Loma Linda University Medical Center...
The Odds Of Surviving Colon Cancer Improve If You Are Married
6/23/2011
A new study shows that being married boosts survival odds for both men and women with colon cancer at every stage of the disease. Married patients had a 14 percent lower risk of death according to researchers at Penn State's College of Medicine and Brigham Young University. That estimate is based on analysis of 127,753 patient records...
UF Review Of Resveratrol Studies Confirms Potential Health Boost
6/23/2011
A University of Florida review of research finds the polyphenol compound known as resveratrol found in red wine, grapes and other fruits may not prevent old age, but it might make it more tolerable. News stories have long touted resveratrol as a cure for various diseases and a preventative against aging. "We're all looking for an anti-aging cure in a pill, but it doesn't exist...
New Graphic Cigarette Warnings In USA Nothing New When Compared To Some Countries
6/22/2011
The nine graphic health warnings to appear on every pack of cigarettes in America, announced by the FDA, are fairly tame when compared to what some countries' authorities have introduced. In Thailand there are disturbing images, one including a tracheotomy and rotting teeth. In Brazil, some of the graphics displayed are very shocking...
CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network (UHN)...
CEL-SCI Corporation (NYSE Amex: CVM) announced today data from its Phase II clinical studies which showed that its lead drug Multikine was able to lower cholesterol in studies involving 120 head and neck cancer patients. The studies were primarily designed to determine the safety and efficacy of the drug in head and neck cancer patients...
Mayo Clinic Researchers Use Human Vaccine To Cure Prostate Cancer In Mice
6/22/2011
Mayo Clinic investigators and collaborators from the United Kingdom cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. This novel cancer treatment approach encourages the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation treatments...
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), announced today the completion of patient enrollment into the Company's Phase 2 pancreatic cancer study with TH-302, a novel small molecule tumor selective Hypoxia-Activated Prodrug (HAP) that specifically targets tumor hypoxia and is applicable to a broad range of solid tumors. Enrollment in the study exceeded initial recruitment expectations...
The Lancet Oncology today publishes a summary from a meeting of the International Agency for Research on Cancer (IARC), that classifies radiofrequency electromagnetic fields (RF-EMF) (including those caused by mobile phones) as possibly carcinogenic to humans (division 2B in the IARC classification)...